Skip to main content
SpringerLink
Log in

The Outlook for Novel Pharmaceutics

  • Chapter
  • First Online:
The Future Circle of Healthcare

Part of the book series: Future of Business and Finance ((FBF))

Abstract

Recent advances in treatment and prevention using novel approaches are opening the door for a seismic shift in healthcare. In this chapter, we report advances in four key areas of personalised medicine: tissue engineering, regenerative medicine, gene therapy, and nanomedicine. We include examples of products currently in the market, barriers to translating these novel therapies to the clinic, and the outlook for emerging therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abreu, T. R., Fonseca, N. A., Gonçalves, N., & Moreira, J. N. (2020). Current challenges and emerging opportunities of CAR-T cell therapies. Journal of Controlled Release, 319, 246–261.

    Article  Google Scholar 

  • Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C. C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., Lin, K. P., Vita, G., Attarian, S., Planté-Bordeneuve, V., Mezei, M. M., Campistol, J. M., Buades, J., Brannagan, T. H., Kim, B. J., Oh, J., Parman, Y., Sekijima, Y., Hawkins, P. N., Solomon, S. D., Polydefkis, M., Dyck, P. J., Gandhi, P. J., Goyal, S., Chen, J., Strahs, A. L., Nochur, S. V., Sweetser, M. T., Garg, P. P., Vaishnaw, A. K., Gollob, J. A., Suhr, O. B. (2018). Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. New England Journal of Medicine, 379(1), 11–21.

    Article  Google Scholar 

  • Anselmo, A. C., & Mitragotri, S. (2016). Nanoparticles in the clinic. Bioengineering and Translation Medicine, 1(1), 10–29.

    Article  Google Scholar 

  • Anselmo, A. C., & Mitragotri, S. (2019). Nanoparticles in the clinic: An update. Bioengineering and Translation Medicine, 4(3), e10143.

    Article  Google Scholar 

  • Balkrishna, A., Arya, V., Rohela, A., Kumar, A., Verma, R., Kumar, D., Nepovimova, E., Kuca, K., Thakur, N., Thakur, N., & Kumar, P. (2021). Nanotechnology interventions in the management of COVID-19: Prevention, diagnosis and virus-like particle vaccines. Vaccine, 9(10), 1129.

    Article  Google Scholar 

  • Bressler, N. M., & Bressler, S. B. (2000). Photodynamic therapy with verteporfin (Visudyne): Impact on ophthalmology and visual sciences [Review]. Investigative Ophthalmology and Visual Science, 41(3), 624–628.

    Google Scholar 

  • Brokowski, C., & Adli, M. (2020). Ethical considerations in therapeutic clinical trials involving novel human germline-editing technology. CRISPR Journal, 3(1), 18–26.

    Article  Google Scholar 

  • Bulaklak, K., & Gersbach, C. A. (2020). The once and future gene therapy. Nature Communications, 11(1), 5820.

    Article  Google Scholar 

  • Cevher, E., Sezer, A. D., & ÇaÄŸlar, E. (2012). Gene delivery systems: Recent progress in viral and non-viral therapy. In A. D. Sezer (Ed.), Recent advances in novel drug carrier systems (pp. 437–470). INTECH.

    Google Scholar 

  • Emancipator, K. (2020). Keytruda and PD-L1: A real-world example of co-development of a drug with a predictive biomarker. AAPS Journal, 23(1), 5.

    Article  Google Scholar 

  • Gadekar, V., Borade, Y., Kannaujia, S., Rajpoot, K., Anup, N., Tambe, V., Kalia, K., & Tekade, R. K. (2021). Nanomedicines accessible in the market for clinical interventions. Journal of Controlled Release, 330, 372–397.

    Article  Google Scholar 

  • Germain, M., Caputo, F., Metcalfe, S., Tosi, G., Spring, K., Ã…slund, A. K. O., Pottier, A., Schiffelers, R., Ceccaldi, A., & Schmid, R. (2020). Delivering the power of nanomedicine to patients today. Journal of Controlled Release, 326, 164–171.

    Article  Google Scholar 

  • Han, F., Wang, J., Ding, L., Hu, Y., Li, W., Yuan, Z., Guo, Q., Zhu, C., Yu, L., Wang, H., Zhao, Z., Jia, L., Li, J., Yu, Y., Zhang, W., Chu, G., Chen, S., & Li, B. (2020). Tissue engineering and regenerative medicine: Achievements, future, and sustainability in Asia [Review]. Frontiers in Bioengineering and Biotechnology, 8, 83.

    Article  Google Scholar 

  • Hernandez-Alcoceba, R., Poutou, J., Ballesteros-Briones, M. C., & Smerdou, C. (2016). Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12. Immunotherapy, 8(2), 179–198.

    Article  Google Scholar 

  • Hersi, A.-F., Eriksson, S., Ramos, J., Abdsaleh, S., Wärnberg, F., & Karakatsanis, A. (2019). A combined, totally magnetic technique with a magnetic marker for non-palpable tumour localization and superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in breast cancer surgery. European Journal of Surgical Oncology, 45(4), 544–549.

    Article  Google Scholar 

  • Lostalé-Seijo, I., & Montenegro, J. (2018). Synthetic materials at the forefront of gene delivery. Nature Reviews Chemistry, 2(10), 258–277.

    Article  Google Scholar 

  • Lu, R.-M., Hwang, Y.-C., Liu, I. J., Lee, C.-C., Tsai, H.-Z., Li, H.-J., & Wu, H.-C. (2020). Development of therapeutic antibodies for the treatment of diseases. Journal of Biomedical Science, 27(1), 1.

    Article  Google Scholar 

  • Manjunath, N., Yi, G., Dang, Y., & Shankar, P. (2013). Newer gene editing technologies toward HIV gene therapy. Viruses, 5(11), 2748–2766.

    Article  Google Scholar 

  • Mao, A. S., & Mooney, D. J. (2015). Regenerative medicine: Current therapies and future directions. Proceedings of the National Academy of Sciences, 112(47), 14452–14459.

    Article  Google Scholar 

  • McCabe, C., & Sipp, D. (2016). Undertested and overpriced: Japan issues first conditional approval of stem cell product. Cell Stem Cell, 18(4), 436–437.

    Article  Google Scholar 

  • Moore, J. P. (2021). Approaches for optimal use of different COVID-19 vaccines: Issues of viral variants and vaccine efficacy. JAMA, 325(13), 1251–1252.

    Article  Google Scholar 

  • Munawar, A., Ong, Y., Schirhagl, R., Tahir, M. A., Khan, W. S., & Bajwa, S. Z. (2019). Nanosensors for diagnosis with optical, electric and mechanical transducers. RSC Advances, 9(12), 6793–6803.

    Article  Google Scholar 

  • Nayerossadat, N., Maedeh, T., & Ali, P. A. (2012). Viral and nonviral delivery systems for gene delivery. Advanced Biomedical Research, 1, 127.

    Article  Google Scholar 

  • Sankar, P. L., & Parker, L. S. (2017). The precision medicine Initiative’s all of us research program: An agenda for research on its ethical, legal, and social issues. Genetics in Medicine, 19(7), 743–750.

    Article  Google Scholar 

  • Schilsky, R. L. (2010). Personalized medicine in oncology: The future is now. Nature Reviews Drug Discovery, 9(5), 363–366.

    Article  Google Scholar 

  • Schmidt, C. (2012). Gintuit cell therapy approval signals shift at US regulator. Nature Biotechnology, 30(6), 479.

    Article  Google Scholar 

  • Sipp, D. (2015). Conditional approval: Japan lowers the bar for regenerative medicine products. Cell Stem Cell, 16(4), 353–356.

    Article  Google Scholar 

  • Sung, Y. K., & Kim, S. W. (2019). Recent advances in the development of gene delivery systems. Biomaterials Research, 23(1), 8.

    Article  Google Scholar 

  • Tachibana, M., Amato, P., Sparman, M., Woodward, J., Sanchis, D. M., Ma, H., Gutierrez, N. M., Tippner-Hedges, R., Kang, E., & Lee, H.-S. (2013). Towards germline gene therapy of inherited mitochondrial diseases. Nature, 493(7434), 627–631.

    Article  Google Scholar 

  • Thomas, G., Boudon, J., Maurizi, L., Moreau, M., Walker, P., Severin, I., Oudot, A., Goze, C., Poty, S., Vrigneaud, J.-M., Demoisson, F., Denat, F., Brunotte, F., & Millot, N. (2019). Innovative magnetic nanoparticles for PET/MRI bimodal imaging. ACS Omega, 4(2), 2637–2648.

    Article  Google Scholar 

  • Tijsterman, M., Ketting, R. F., & Plasterk, R. H. (2002). The genetics of RNA silencing. Annual Review of Genetics, 36(1), 489–519.

    Article  Google Scholar 

  • Tombal, B., & Berges, R. (2006). Eligard®: Advantages for optimal testosterone control. European Urology Supplements, 5(18), 900–904.

    Article  Google Scholar 

  • Vinatier, C., & Guicheux, J. (2016). Cartilage tissue engineering: From biomaterials and stem cells to osteoarthritis treatments. Annals of Physical and Rehabilitation Medicine, 59(3), 139–144.

    Article  Google Scholar 

  • Wagner, V., Dullaart, A., Bock, A.-K., & Zweck, A. (2006). The emerging nanomedicine landscape. Nature Biotechnology, 24(10), 1211–1217.

    Article  Google Scholar 

  • Wilson, B. J., & Nicholls, S. G. (2015). The human genome project, and recent advances in personalized genomics. Risk Management and Healthcare Policy, 8, 9–20.

    Article  Google Scholar 

  • Zaulyanov, L., & Kirsner, R. S. (2007). A review of a bi-layered living cell treatment (Apligraf©) in the treatment of venous leg ulcers and diabetic foot ulcers. Clinical Interventions in Aging, 2(1), 93–98.

    Article  Google Scholar 

Download references

Acknowledgements

The authors declare no potential conflicts of interest.

Author information

Authors and Affiliations

  1. School of Pharmacy, University College London, London, UK

    Maryam Parhizkar

  2. Department of Chemical and Process Engineering, University of Surrey, Guildford, UK

    Dimitrios Tsaoulidis

Authors
  1. Maryam Parhizkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dimitrios Tsaoulidis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maryam Parhizkar .

Editor information

Editors and Affiliations

  1. Department of Philosophy, University College London, London, UK

    Sepehr Ehsani

  2. Applied Computer Science, Deggendorf Institute of Technology, Deggendorf, Bayern, Germany

    Patrick Glauner

  3. SRH University of Applied Health Sciences Campus Rheinland, Leverkusen, Rhine-Westphalia, Germany

    Philipp Plugmann

  4. Cranio-Maxillo-Facial Surgery, and 3D Print Lab, University Hospital Basel, Basel, Basel-Stadt, Switzerland

    Florian M. Thieringer

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Parhizkar, M., Tsaoulidis, D. (2022). The Outlook for Novel Pharmaceutics. In: Ehsani, S., Glauner, P., Plugmann, P., Thieringer, F.M. (eds) The Future Circle of Healthcare. Future of Business and Finance. Springer, Cham. https://doi.org/10.1007/978-3-030-99838-7_16

Download citation

Publish with us

Policies and ethics

Search

Navigation